Menu
Search
Home > Courses > New Drugs and Strategies in the Treatment of HIV Disease

New Drugs and Strategies in the Treatment of HIV Disease

New Drugs and Strategies in the Treatment of HIV Disease
Sorry, this learning module is not available for mobile devices.
This video is available at the Physicians Research Network website.

Original Release Date: 9/21/2010
Review Date: 9/21/2010
Presenter
  • Calvin J. Cohen, MD, MS
    Research Director for the Community Research Initiative of New England and Harvard Vanguard Medical Associates
    Harvard Medical School
Learning Objectives / Desired Outcomes
At the completion of this educational activity, participants will:
  1. Review data on drugs in phase 3 of development for the treatment of HIV disease.
  2. Describe new strategies for combining antiretroviral agents.
  3. Discuss data on 2-drug combinations and induction/maintenance in the treatment of HIV disease.
Presenter Bio
Calvin Cohen, MD, MS
Cal Cohen is the Research Director of Community Research Initiative of New England, Clinical Research Director for Harvard Vanguard Medical Associates, and a Clinical Instructor at Harvard Medical School. Dr. Cohen earned his M.D. from the Albert Einstein College of Medicine, and his M.Sc. from the Harvard School of Public Health. Dr. Cohen's research has focused on HIV antiviral trials since 1985, and he is currently a Vice-chair of the Scientific Steering Committee of the INSIGHT network, an NIH-supported International network of clinician-researchers. He received the Outstanding Physician Award by Harvard Vanguard Medical Associates, and the Ebert Teaching award by Harvard Pilgrim Health Care.
PRN Learning Modules